'4+1' Mixed Ligand Strategy for the Preparation of 99mTc-Radiopharmaceuticals for Hypoxia Detecting Applications
dc.contributor.author | Vats, K. | |
dc.contributor.author | Mallia, M. B. | |
dc.contributor.author | Mathur, A. | |
dc.contributor.author | Sarma, H. D. | |
dc.contributor.author | Banerjee, S. | |
dc.date.accessioned | 2018-06-18T05:35:21Z | |
dc.date.available | 2018-06-18T05:35:21Z | |
dc.date.issued | 2017 | |
dc.description.division | RPhD;RB&HSD;RMC | en |
dc.format.extent | 4638 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | ChemistrySelect, 2017. Vol. 2 (10): pp. 2910-2916 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/16467 | |
dc.language.iso | en | en |
dc.subject | '4+1' Mixed Ligand Strategy | en |
dc.subject | 99mTc-Radiopharmaceuticals | en |
dc.subject | Hypoxia Detecting Applications | en |
dc.subject | Preliminary biological evaluation | en |
dc.title | '4+1' Mixed Ligand Strategy for the Preparation of 99mTc-Radiopharmaceuticals for Hypoxia Detecting Applications | en |
dc.type | Article | en |